Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

OBJECTIVE: To ascertain the surgical risk and long term outcome of patients over 80 years old undergoing aortic valve replacement (AVR). DESIGN: Consecutive cases with respective case note audit and a telephone questionnaire. SETTING: Single UK cardiothoracic surgical centre. PATIENTS: 103 (48 male) patients over 80 years old undergoing AVR. The median age was 82 years (80-95 years) and 95 of 103 patients were in New York Heart Association (NYHA) class III or IV. METHOD AND RESULTS: Preoperative characteristics, operative course, cost, and outcome measures were ascertained. Mean bypass time was 56 minutes and 25 patients had simultaneous coronary artery bypass grafting. Overall mortality was 19 of 103. Univariate analysis of pertinent variables found that impaired renal function and peripheral vascular disease were significantly associated with early postoperative death. 10 of 12 patients requiring ventilation for more than 24 hours died. The 50% actuarial survival was 62 months. Late complications were uncommon with 92% of patients in NYHA class I or II at follow up. CONCLUSIONS: AVR in patients over 80 years old has a significant risk. However, those patients who survive experience significant benefit with good long term prospects for general health and social independence.

Original publication

DOI

10.1136/hrt.82.2.138

Type

Journal article

Journal

Heart

Publication Date

08/1999

Volume

82

Pages

138 - 142

Keywords

Aged, Aged, 80 and over, Aortic Valve, Aortic Valve Stenosis, Coronary Artery Bypass, Costs and Cost Analysis, Female, Heart Valve Prosthesis Implantation, Humans, Kidney Diseases, Male, Peripheral Vascular Diseases, Retrospective Studies, Risk Factors, Survival Rate, Treatment Outcome